Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Loss of immune homeostasis dictates SHIV rebound after stem-cell transplantation
Christopher W. Peterson, Clarisse Benne, Patricia Polacino, Jasbir Kaur, Cristina E. McAllister, Abdelali Filali-Mouhim, Willi Obenza, Tiffany A. Pecor, Meei-Li Huang, Audrey Baldessari, Robert D. Murnane, Ann E. Woolfrey, Keith R. Jerome, Shiu-Lok Hu, Nichole R. Klatt, Stephen DeRosa, Rafick P. Sékaly, Hans-Peter Kiem
Christopher W. Peterson, Clarisse Benne, Patricia Polacino, Jasbir Kaur, Cristina E. McAllister, Abdelali Filali-Mouhim, Willi Obenza, Tiffany A. Pecor, Meei-Li Huang, Audrey Baldessari, Robert D. Murnane, Ann E. Woolfrey, Keith R. Jerome, Shiu-Lok Hu, Nichole R. Klatt, Stephen DeRosa, Rafick P. Sékaly, Hans-Peter Kiem
View: Text | PDF
Research Article AIDS/HIV Transplantation

Loss of immune homeostasis dictates SHIV rebound after stem-cell transplantation

  • Text
  • PDF
Abstract

The conditioning regimen used as part of the Berlin patient’s hematopoietic cell transplant likely contributed to his eradication of HIV infection. We studied the impact of conditioning in simian-human immunodeficiency virus–infected (SHIV-infected) macaques suppressed by combination antiretroviral therapy (cART). The conditioning regimen resulted in a dramatic, but incomplete depletion of CD4+ and CD8+ T cells and CD20+ B cells, increased T cell activation and exhaustion, and a significant loss of SHIV-specific Abs. The disrupted T cell homeostasis and markers of microbial translocation positively correlated with an increased viral rebound after cART interruption. Quantitative viral outgrowth and Tat/rev–induced limiting dilution assays showed that the size of the latent SHIV reservoir did not correlate with viral rebound. These findings identify perturbations of the immune system as a mechanism for the failure of autologous transplantation to eradicate HIV. Thus, transplantation strategies may be improved by incorporating immune modulators to prevent disrupted homeostasis, and gene therapy to protect transplanted cells.

Authors

Christopher W. Peterson, Clarisse Benne, Patricia Polacino, Jasbir Kaur, Cristina E. McAllister, Abdelali Filali-Mouhim, Willi Obenza, Tiffany A. Pecor, Meei-Li Huang, Audrey Baldessari, Robert D. Murnane, Ann E. Woolfrey, Keith R. Jerome, Shiu-Lok Hu, Nichole R. Klatt, Stephen DeRosa, Rafick P. Sékaly, Hans-Peter Kiem

×
Options: View larger image (or click on image) Download as PowerPoint
Correlation between simian-human immunodeficiency virus peak viral rebou...

Correlation between simian-human immunodeficiency virus peak viral rebound, T cell subsets, and microbial translocation markers


Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts